Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
counterproductive to the overall management<br />
objectives. Propranolol blocks<br />
the positive <strong>in</strong>otropic and chronotropic<br />
effect <strong>of</strong> hydralaz<strong>in</strong>e upon the heart and<br />
the comb<strong>in</strong>ed therapy prevents <strong>in</strong>crease<br />
<strong>in</strong> uter<strong>in</strong>e blood flow. A less satisfactory<br />
alternative antihypertensive agent is the<br />
rauwolfia compound, Reserp<strong>in</strong>e, which<br />
can be given both parenterally and orally<br />
with good effect. The side effects such<br />
as nasal congestion <strong>in</strong> the neonate are<br />
manageable with good neonatal nursery<br />
care. The maternal risk <strong>of</strong> catecholam<strong>in</strong>e<br />
depletion <strong>in</strong> the event <strong>of</strong> a general anaesthetic<br />
is also manageable <strong>in</strong> competent<br />
hands.<br />
Group III: The emergency management<br />
<strong>of</strong> an acute hypertensive crisis presents<br />
the greatest challenge to the obstetrical<br />
team. The patient with diastolic pressure<br />
<strong>of</strong> 115 mm Hg may very well present<br />
with massive peripheral edema and<br />
impend<strong>in</strong>g or frank pulmonary edema. In<br />
these patients aggressive medical<br />
management <strong>in</strong> an <strong>in</strong>tensive care sett<strong>in</strong>g<br />
is directed toward maternal survival and<br />
prevention <strong>of</strong> fetal sequelae.<br />
Management may progress on several<br />
fronts at the same time hydralaz<strong>in</strong>e <strong>in</strong><br />
appropriate doses should be started at<br />
once by <strong>in</strong>travenous route. Pulmonary<br />
edema should be treated by aggressive<br />
management such as <strong>in</strong>tra-venous<br />
<strong>in</strong>fusion <strong>of</strong> frusemide, <strong>in</strong> doses <strong>of</strong> 40 to<br />
80 mg. The fetal prognosis <strong>in</strong> these acute<br />
situations is generally very poor. The<br />
rapid lower<strong>in</strong>g <strong>of</strong> the arterial pressure,<br />
for maternal <strong>in</strong>dication, may further<br />
compromise uteroplacental perfusion.<br />
Fulm<strong>in</strong>at<strong>in</strong>g disease - When the B.P is<br />
more than 160/110 and edema and<br />
prote<strong>in</strong>uria along with headache and<br />
epigastric pa<strong>in</strong> are present, the danger <strong>of</strong><br />
oliguria and imm<strong>in</strong>ent convulsions<br />
56<br />
becomes very real, therefore anticonvulsant<br />
drugs should be given to<br />
avoid convulsions. Antihypertensive agents<br />
to avoid <strong>in</strong>tracranial hemorrhage<br />
and delivery should be planned without<br />
delay to deliver live <strong>in</strong>fant <strong>in</strong> such cases.<br />
Follow-up:<br />
For patients with BP stabilized by<br />
management, follow up should normally<br />
be three monthly (<strong>in</strong>terval should not<br />
exceed 6 months), at which the follow<strong>in</strong>g<br />
should be assessed by a tra<strong>in</strong>ed<br />
nurse:<br />
* Measurement <strong>of</strong> BP and weight<br />
* Re<strong>in</strong>forcement <strong>of</strong> non-<br />
Pharmacological advice<br />
* General health and drug side-<br />
effects.<br />
* Test ur<strong>in</strong>e for prote<strong>in</strong>uria<br />
(annually)<br />
High risk pregnancy units which are<br />
equipped with <strong>in</strong>tensive care facilities<br />
for mother and the neonate can help<br />
improve results <strong>of</strong> maternal orbidity and<br />
neonatal survival.<br />
Usually rapid improvement <strong>in</strong> patient’s<br />
blood pressure occurs follow<strong>in</strong>g delivery<br />
but occ-asionally there may be transient<br />
wor-sen<strong>in</strong>g. Fits may occur with<strong>in</strong> 24<br />
hours <strong>of</strong> delivery but rarely thereafter,<br />
therefore, the patient must be observed<br />
and treated at least for 24 hours after<br />
delivery.<br />
Term<strong>in</strong>ation <strong>of</strong> pregnancy:<br />
It may be justified <strong>in</strong> milder cases to<br />
temporize with premature babies. The<br />
chance <strong>of</strong> survival <strong>of</strong> low birth weight<br />
fetus is greater <strong>in</strong> neonatal <strong>in</strong>tensive care<br />
unit than if left <strong>in</strong> utero. If it is decided